News|Articles|October 21, 2024
Q&A: What Pharmacists Need to Know about Onyda XR for the Treatment of ADHD
Author(s)Killian Meara
A conversation with Rakesh Jain, MD, MPH, clinical professor in the Department of Psychiatry at Texas Tech University School of Medicine.
Advertisement
Advertisement
Clonidine hydrochloride (Onyda XR) was approved by the FDA in May 2024 for the treatment of ADHD in pediatric patients 6 years of age and older. The medication, which is now available in the United States, is a once-daily, extended release, oral suspension medication and is the first liquid, non-stimulant for ADHD approved in the country.
Advertisement
Advertisement